Pharma stocks under pressure, tank over 10 per cent as Trump hints at 'never seen before' tariffs

CSL, other big drug makers could be Trump’s next targets

The Health Minister said that while pharmaceutical groups like CSL were currently exempt, officials expected more trade barriers to build domestic capacity.

Pharmaceuticals have traditionally been a defensive sector for investors. A haven at times of high volatility due to predictable cash flows and a generous dividend supported by long-term patent ownership. On Thursday, when the Stock Exchanges collapsed because of Trump’s tariffs, some of them demonstrated this: AstraZeneca and GSK not only dodged losses, but ended up with revaluations above 1% and Sanofi contained the blow with a drop of only 0.…

Taiwan's drug sector concerned about impact of U.S. tariff plan - Focus Taiwan

Taipei, April 5 (CNA) U.S. President Donald Trump's plan to impose tariffs on imported semiconductors and pharmaceuticals has raised concerns in Taiwan's drug sector, industry insiders said on Saturday.

Pharma Companies Likely to See Up to 16 Pc Sales Growth in FY25: Centrum Report

Get latest articles and stories on Business at LatestLY. India's leading pharmaceutical companies are expected to report strong sales growth of up to 16 per cent year-on-year (YoY) in the financial year 2024-25, according to a report by Centrum Institutional Research. Business News | Pharma Companies Likely to See Up to 16 Pc Sales Growth in FY25: Centrum Report.

Pharma stocks under pressure, tank over 10 per cent as Trump hints at 'never seen before' tariffs

Cipla Share Price, Sun Pharma Share Price: Shares of pharmaceutical companies are under pressure on Friday, i.e. April 4, 2025, after US President Donald Trump said that the sector will see 'never seen before' tariffs. As a result, the Nifty Pharma index fell over 6 per cent after opening in the green today. Nifty Pharma had started the session in green at 21,430.95 against the previous close of 21,423.55.  Following the US President's remark, s…

Stock Market Highlights: Trump tariff exemption boosts pharma but Nifty muted, ends below 23,300

Share Market Highlight | BSE Sensex, Nifty 50 Today: Indian equity markets slipped during Thursday's trade after Trump announced 26% tariffs on foreign imports to the US.